A9575 HCPCS Level II code: Injection, gadoterate meglumine, 0.1 ml
A9575 is the HCPCS code for “Injection, gadoterate meglumine, 0.1 ml” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
A9575Injection, gadoterate meglumine, 0.1 ml
Short description: Inj gadoterate meglumi 0.1ml
HCPCS · United States
Medicare details
The indicators CMS publishes with A9575 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Other carrier priced
- Type of service
- Diagnostic radiology
- BETOS category
- Standard imaging - nuclear medicine
- Added
- Jan 1, 2014
Where A9575 sits
- 1A codesAmbulance, supplies and miscellaneous
- 2Active code A9575Injection, gadoterate meglumine, 0.1 ml
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code A9575 mean?
A9575 is the HCPCS code for “Injection, gadoterate meglumine, 0.1 ml” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover A9575?
CMS lists A9575’s Medicare coverage as “Carrier judgment” and its pricing as “Other carrier priced”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside A9575
All A codesA9569Technetium tc-99m exametazime labeled autologous white blood cells, diagnostic, per study doseA9570Indium in-111 labeled autologous white blood cells, diagnostic, per study doseA9571Indium in-111 labeled autologous platelets, diagnostic, per study doseA9572Indium in-111 pentetreotide, diagnostic, per study dose, up to 6 millicuriesA9573Injection, gadopiclenol, 1 mlA9574Injection, ferumoxytol, 1 mgA9576Injection, gadoteridol, (prohance multipack), per mlA9577Injection, gadobenate dimeglumine (multihance), per mlA9578Injection, gadobenate dimeglumine (multihance multipack), per mlA9579Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per mlA9580Sodium fluoride f-18, diagnostic, per study dose, up to 30 millicuriesA9581Injection, gadoxetate disodium, 1 ml